Would you buy Avanex? Earnings for the week starting 23Dec24

KYHBKO

12-23 13:22

Earnings Calendar (23Dec24)

Due to the holiday season, there are 2 notable earnings this week - Anavex and Limoneira.

Let us look at Anavex.

Who is Anavex?

Anavex has clocked a price decline of 3.6% from a year ago.

The EPS is -0.50 and thus, has a (negative) P/E ratio of -17.2

From the technical analysis, it has a “Neutral” rating.

From Analysts Sentiment, it has a recommendation for “Strong Buy”. Its price target of $35.472 implies an upside of 311.031%.

The company has yet to generate any revenue, making a loss from the last 10 years as per the screenshot above.

The operating losses peaked at $56M in 2023.

For the coming earnings, the forecast of its EPS and Revenue are -0.157 and no revenue respectively.

It seems that the company will end the last quarter with a loss. There are some products in clinical trials and the outlook of these would be important for the business.

I do not know this industry adequately and prefer to skip Avanex.

@TigerStars

💰 Stocks to watch today?(25 Dec)

1. What news/movements are worth noting in the market today? Any stocks to watch? 2. What trading opportunities are there? Do you have any plans? 🎁 Make a post here, everyone stands a chance to win Tiger coins!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

TimothyBarnes
12-23 14:11
TimothyBarnes
Interesting analysis
- KYHBKO:
  thanks. I am probably using a framework that needs to be refined

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":384530150040104,"tweetId":"384530150040104","gmtCreate":1734931372953,"gmtModify":1734934149459,"author":{"id":3574381076586256,"idStr":"3574381076586256","authorId":3574381076586256,"authorIdStr":"3574381076586256","name":"KYHBKO","avatar":"https://static.tigerbbs.com/c3bcbc7f9a10836dea92afc94bf39b5b","vip":2,"userType":2,"introduction":"Let us create value through sharing of insights & exchange of ideas","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.25","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":10609,"starInvestorFlag":false},"themes":[{"themeId":"470d3ab575ca43caaed8156645b7ccbe","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"💰 Stocks to watch today?(25 Dec)","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":470d3ab575ca43caaed8156645b7ccbe}&rnconfig={\"headerBarHidden\": true}","description":"1. What news/movements are worth noting in the market today? Any stocks to watch? \n2. What trading opportunities are there? Do you have any plans?\n🎁 Make a post here, everyone stands a chance to win Tiger coins!","image":"https://static.tigerbbs.com/cd8eaff2e99964ab7a80d92cc196fcd3"}],"images":[{"img":"https://community-static.tradeup.com/news/ecc98968f6cab49064bfca99e7636c1f","width":"1456","height":"819"},{"img":"https://community-static.tradeup.com/news/3d0ed9f37d5050079c7f7f8832c2b66f","width":"1084","height":"538"},{"img":"https://community-static.tradeup.com/news/25c8c01902545d73544f88feeb3a9344","width":"1456","height":"863"},{"img":"https://community-static.tradeup.com/news/57855f6e7ad05ff50b711ac356773bc0","width":"1456","height":"743"},{"img":"https://community-static.tradeup.com/news/facaffdecb730171f12633fb4894b2f0","width":"1456","height":"956"},{"img":"https://community-static.tradeup.com/news/b8bc541026e5ef41e7a083dffad2fb1c","width":"934","height":"560"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/ecc98968f6cab49064bfca99e7636c1f","width":"1456","height":"819"},{"img":"https://community-static.tradeup.com/news/3d0ed9f37d5050079c7f7f8832c2b66f","width":"1084","height":"538"},{"img":"https://community-static.tradeup.com/news/25c8c01902545d73544f88feeb3a9344","width":"1456","height":"863"}],"title":"Would you buy Avanex? Earnings for the week starting 23Dec24","html":"<html><head></head><body><h2>Earnings Calendar (23Dec24)</h2>\n<img src=\"https://community-static.tradeup.com/news/ecc98968f6cab49064bfca99e7636c1f\" tg-width=\"1456\" tg-height=\"819\">\nDue to the holiday season, there are 2 notable earnings this week - Anavex and Limoneira.\nLet us look at Anavex.\n\nWho is Anavex?\n<img src=\"https://community-static.tradeup.com/news/3d0ed9f37d5050079c7f7f8832c2b66f\" tg-width=\"1084\" tg-height=\"538\">\n<img src=\"https://community-static.tradeup.com/news/25c8c01902545d73544f88feeb3a9344\" tg-width=\"1456\" tg-height=\"863\">\nAnavex has clocked a price decline of 3.6% from a year ago.\nThe EPS is -0.50 and thus, has a (negative) P/E ratio of -17.2\n<img src=\"https://community-static.tradeup.com/news/57855f6e7ad05ff50b711ac356773bc0\" tg-width=\"1456\" tg-height=\"743\">\nFrom the technical analysis, it has a “Neutral” rating.\nFrom Analysts Sentiment, it has a recommendation for “Strong Buy”. Its price target of $35.472 implies an upside of 311.031%.\n<img src=\"https://community-static.tradeup.com/news/facaffdecb730171f12633fb4894b2f0\" tg-width=\"1456\" tg-height=\"956\">\nThe company has yet to generate any revenue, making a loss from the last 10 years as per the screenshot above.\nThe operating losses peaked at $56M in 2023.\n<img src=\"https://community-static.tradeup.com/news/b8bc541026e5ef41e7a083dffad2fb1c\" tg-width=\"934\" tg-height=\"560\">\nFor the coming earnings, the forecast of its EPS and Revenue are -0.157 and no revenue respectively.\nIt seems that the company will end the last quarter with a loss. There are some products in clinical trials and the outlook of these would be important for the business.\nI do not know this industry adequately and prefer to skip Avanex.\n\n<a href=\"https://ttm.financial/U/9000000000000149\">@TigerStars</a></body></html>","htmlText":"<html><head></head><body><h2>Earnings Calendar (23Dec24)</h2>\n<img src=\"https://community-static.tradeup.com/news/ecc98968f6cab49064bfca99e7636c1f\" tg-width=\"1456\" tg-height=\"819\">\nDue to the holiday season, there are 2 notable earnings this week - Anavex and Limoneira.\nLet us look at Anavex.\n\nWho is Anavex?\n<img src=\"https://community-static.tradeup.com/news/3d0ed9f37d5050079c7f7f8832c2b66f\" tg-width=\"1084\" tg-height=\"538\">\n<img src=\"https://community-static.tradeup.com/news/25c8c01902545d73544f88feeb3a9344\" tg-width=\"1456\" tg-height=\"863\">\nAnavex has clocked a price decline of 3.6% from a year ago.\nThe EPS is -0.50 and thus, has a (negative) P/E ratio of -17.2\n<img src=\"https://community-static.tradeup.com/news/57855f6e7ad05ff50b711ac356773bc0\" tg-width=\"1456\" tg-height=\"743\">\nFrom the technical analysis, it has a “Neutral” rating.\nFrom Analysts Sentiment, it has a recommendation for “Strong Buy”. Its price target of $35.472 implies an upside of 311.031%.\n<img src=\"https://community-static.tradeup.com/news/facaffdecb730171f12633fb4894b2f0\" tg-width=\"1456\" tg-height=\"956\">\nThe company has yet to generate any revenue, making a loss from the last 10 years as per the screenshot above.\nThe operating losses peaked at $56M in 2023.\n<img src=\"https://community-static.tradeup.com/news/b8bc541026e5ef41e7a083dffad2fb1c\" tg-width=\"934\" tg-height=\"560\">\nFor the coming earnings, the forecast of its EPS and Revenue are -0.157 and no revenue respectively.\nIt seems that the company will end the last quarter with a loss. There are some products in clinical trials and the outlook of these would be important for the business.\nI do not know this industry adequately and prefer to skip Avanex.\n\n<a href=\"https://ttm.financial/U/9000000000000149\">@TigerStars</a></body></html>","text":"Earnings Calendar (23Dec24) Due to the holiday season, there are 2 notable earnings this week - Anavex and Limoneira. Let us look at Anavex. Who is Anavex? Anavex has clocked a price decline of 3.6% from a year ago. The EPS is -0.50 and thus, has a (negative) P/E ratio of -17.2 From the technical analysis, it has a “Neutral” rating. From Analysts Sentiment, it has a recommendation for “Strong Buy”. Its price target of $35.472 implies an upside of 311.031%. The company has yet to generate any revenue, making a loss from the last 10 years as per the screenshot above. The operating losses peaked at $56M in 2023. For the coming earnings, the forecast of its EPS and Revenue are -0.157 and no revenue respectively. It seems that the company will end the last quarter with a loss. There are some products in clinical trials and the outlook of these would be important for the business. I do not know this industry adequately and prefer to skip Avanex. @TigerStars","highlighted":1,"essential":1,"paper":2,"likeSize":10,"commentSize":2,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/384530150040104","repostId":0,"isVote":1,"tweetType":1,"viewCount":151,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TIGR"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":795,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":384623979282712,"commentId":"384623979282712","gmtCreate":1734934301097,"gmtModify":1734942324594,"authorId":9000000000000195,"author":{"id":9000000000000195,"idStr":"9000000000000195","authorId":9000000000000195,"name":"TimothyBarnes","avatar":"https://static.tigerbbs.com/106a411ceff67f0e60547585f11948b5","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":384530150040104,"objectIdStr":"384530150040104","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Interesting analysis","text":"Interesting analysis","html":"Interesting analysis","likeSize":1,"commentSize":1,"subComments":[{"id":384736218915080,"commentId":"384736218915080","gmtCreate":1734949250100,"gmtModify":1734949255152,"authorId":3574381076586256,"author":{"id":3574381076586256,"idStr":"3574381076586256","authorId":3574381076586256,"name":"KYHBKO","avatar":"https://static.tigerbbs.com/c3bcbc7f9a10836dea92afc94bf39b5b","vip":2,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.12.25","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":384530150040104,"objectIdStr":"384530150040104","type":1,"supId":384623979282712,"supIdStr":"384623979282712","prevId":0,"prevIdStr":"0","content":"thanks. I am probably using a framework that needs to be refined","text":"thanks. I am probably using a framework that needs to be refined","html":"thanks. I am probably using a framework that needs to be refined"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/384530150040104"}